advertisement

science

the truth about grief: turns out most of us are good at it

columbia university psychologist george a. bonanno says we can be resilient in the face of loss.
nicholas sokic
may 21, 2020

virus fighting cells decrease as we age, study suggests

micrornas that attack invading viruses diminish with age, which may explain the increased covid-19 risk among the elderly.
jordan heuvelmans
may 14, 2020

negativity bias: can we be positive amidst the bleak?

is there a risk that the barrage of bad news can be leading to an unhealthily cynical world view?
nicholas sokic
may 12, 2020

study on genetic mutation suggests covid-19 could 'weaken'

a genetic mutation that weakened the strength of sars has been seen in covid-19.
jordan heuvelmans
may 07, 2020

clinical trials community rises to the covid-19 challenge

there are at least 39 multi-site covid-19 clinical trials and observational studies underway in ontario.
staff, clinical trials ontario
may 05, 2020

birth defect drug tested as treatment for covid-19

morning sickness drug thalidomide attracted attention in the the early 1960's for causing birth defects. now doctors are considering it to treat covid-19.
jordan heuvelmans
may 04, 2020

why making anti-viral drugs is so hard - and how covid-19 could be great for the field

'we’re kind of with anti-virals now where antibiotics were in the 1950s,' said an infectious-disease expert
the national post
may 02, 2020

canada shouldn’t rush to approve promising new covid-19 drug remdesivir: experts

some also worry about a more fundamental problem: whether there would even be enough of the drug to routinely hand it out here
tom blackwell, national post
may 01, 2020
powered by
canadian coalition for seniors’ mental health (ccsmh)
powered by
diabetes canada
powered by
obesity canada

the truth about grief: turns out most of us are good at it

columbia university psychologist george a. bonanno says we can be resilient in the face of loss.
nicholas sokic
may 21, 2020

virus fighting cells decrease as we age, study suggests

micrornas that attack invading viruses diminish with age, which may explain the increased covid-19 risk among the elderly.
jordan heuvelmans
may 14, 2020

negativity bias: can we be positive amidst the bleak?

is there a risk that the barrage of bad news can be leading to an unhealthily cynical world view?
nicholas sokic
may 12, 2020

study on genetic mutation suggests covid-19 could 'weaken'

a genetic mutation that weakened the strength of sars has been seen in covid-19.
jordan heuvelmans
may 07, 2020
powered by
canadian coalition for seniors’ mental health (ccsmh)

clinical trials community rises to the covid-19 challenge

there are at least 39 multi-site covid-19 clinical trials and observational studies underway in ontario.
staff, clinical trials ontario
may 05, 2020

birth defect drug tested as treatment for covid-19

morning sickness drug thalidomide attracted attention in the the early 1960's for causing birth defects. now doctors are considering it to treat covid-19.
jordan heuvelmans
may 04, 2020

why making anti-viral drugs is so hard - and how covid-19 could be great for the field

'we’re kind of with anti-virals now where antibiotics were in the 1950s,' said an infectious-disease expert
the national post
may 02, 2020

canada shouldn’t rush to approve promising new covid-19 drug remdesivir: experts

some also worry about a more fundamental problem: whether there would even be enough of the drug to routinely hand it out here
tom blackwell, national post
may 01, 2020
powered by
diabetes canada
advertisement

advertisement